Navigation Links
Restricted Fetal Growth Increases Risk of Irritable Bowel Syndrome

Babies weighing less than the standard weight seem to be at significantly greater risk of developing irritable bowel syndrome or IBS, suggests research published// ahead of print in the journal Gut.

The Norwegian authors base their findings on 3334 twin pairs, 1250 of whom were identical. The twins completed a comprehensive questionnaire about their health, including whether they had ever had IBS.

This information was then matched with weight at birth, supplied by the national twin registry and divided into four groups, ranging from less than 1500 g to more than 2500 g. A healthy birth weight is considered to be above 2500 g.

The rate of IBS across the entire sample was 5.4%, roughly one in 20. But there was a significant gender difference: the rate in men was 3%, while that in women was 7%.

There was little difference, however, in the average age of onset between the two sexes. The first signs of the condition appeared at the age of 18 in men, and a year earlier in women.

Only one in four of those who reported IBS symptoms at some point in their lives, were symptom free at the time of the survey, and the average duration of their symptoms was more than 4.5 years.

The likelihood of IBS was stronger among the identical twins, suggesting that genetic factors do play a part, say the authors.

But the risk of the condition was 2.5 times greater among those whose birth weights were below 1500 g as it was among those weighing more than 2500 g at birth. And it was higher in the lower weight baby of the twin pair.

The age at which symptoms started also seemed to be associated with birth weight. Those weighing in at less than 1500 g at birth were, on average, likely to develop IBS more than 7 years earlier than those weighing over 1500 g.

The authors point out that several chronic diseases have been linked to low birth weight, and that the healthy development of the dig
'"/>




Page: 1 2

Related medicine news :

1. Restricted Activity Predicts Disability
2. Increase in HIV Cases Due To Restricted Offering of the Preventive Treatment
3. Junk Food Advertisements To Be Restricted In All Forms of Media
4. Junk Food Promotional Ads To Be Restricted: Blair
5. Review Urges Restricted Use Of Devices To Keep Heart Patients Alive
6. Pies Restricted To Once A Term For Kiwi School Kids
7. Fish Found To Improve Fetal Growth
8. Fetal Cell Transplant Found To Improve Movement In Patients With Parkinson’s Disease
9. Vitamin Supplements During Pregnancy to Boost Fetal Development
10. Worried About The Sensitive Skin Of Your 2 Year Old? Fetal Skin Cells To Offer Help
11. Using Eyes As The Line Of Reference For Fetal Brain Imaging
Post Your Comments:
(Date:10/7/2008)... WASHINGTON, Oct. 7 /PRNewswire-USNewswire/ -- ...ecent winner of Dancing With the Stars, has been,n...ation Christmas Seals,Campaign in an effort to hel...sion: to prevent lung disease and promote lung hea...ls tradition began in 1907,to conquer Tuberculosis...
(Date:10/7/2008)...Less likely to feel distress, more likely to enjoy... TUESDAY, Oct. 7 (HealthDay News) -- End-of-life d...atient do not result in more distress for patients...interventions and enhanced quality of life in a pa... "For the past two decades, the debate has been ar...
(Date:10/7/2008)..., Surprise announcement of planned bequest comes .../PRNewswire-USNewswire/ -- Just over one year,ago,...million gift to the,University of Michigan, to end..., treating and preventing human disease., Today, ...n --,announcing that he will bequeath an additiona...
(Date:10/7/2008)...These brain-damaged individuals show signs of awar...AY, Oct. 7 (HealthDay News) -- Severely brain-dam... still feel pain and require painkilling treatment...ally conscious state (MCS) is different than a per...efulness without awareness of self or surroundings...
Breaking Medicine News(10 mins):Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Patients Benefit From End-of-Life Discussions With a Doctor 2Health News:Patients Benefit From End-of-Life Discussions With a Doctor 3Health News:Alfred Taubman Announces New $22M Gift to U-M 2Health News:Patients in Minimally Conscious State May Still Feel Pain 2
...bout one in three children in California is overwe...to statistics released by a health insurance compa... the Los Angeles County, which comprises 88 satell... overweight children in the county is about three ...
...close schools for up to three months in the event ...ould be canceled and working hours //staggered so ...vernment advised today in issuing new pandemic flu...h officials acknowledged that such measures would ...
On the 'Fast Buck' Trail: Kidneys on Sale
...ned from animals that are cloned will not bear any...s safe for consumption, there is no necessary to i... Press, the approval from the U.S. Government on c...s expected within a year. The Food and Drug Admini...
Other Medicine News:Health News:U.S. Issues Guidelines in Case of Flu Pandemic 2Health News:U.S. Issues Guidelines in Case of Flu Pandemic 3Health News:U.S. Issues Guidelines in Case of Flu Pandemic 4Health News:On the 'Fast Buck' Trail: Kidneys on Sale 2Health News:On the 'Fast Buck' Trail: Kidneys on Sale 3Health News:On the 'Fast Buck' Trail: Kidneys on Sale 4Health News:On the 'Fast Buck' Trail: Kidneys on Sale 5Health News:On the 'Fast Buck' Trail: Kidneys on Sale 6Health News:On the 'Fast Buck' Trail: Kidneys on Sale 7
(Date:10/7/2008)... FORT COLLINS, Colo., Oct. 7 /- A...examining embryonic stem cell self-renewal,report...lastim (recombinant,human serum albumin) was an ef...cell culture., The article entitled, "The ground ...sed that researchers used Cellastim as a recombina...
(Date:10/7/2008)... CAMBRIDGE, Mass., Oct. 7 /- Tali... data on several of the Company,s pipeline,candida...ement Workshop in,Basel, Switzerland. The data hig...l models of complement-mediated diseases., "These...vitro studies,presented at the conference, reveal ...
(Date:10/7/2008)... Several abstracts highlighting CIMZIA,s long-...n,s disease patients presented at American College.../- Data from two studies,pr...f Gastroenterology,(ACG) Annual Meeting demonstrat...EGylated anti-TNF alpha (Tumor Necrosis Factor alp...
(Date:10/7/2008)... SAN DIEGO, Oct. 7 /- A...today that a poster entitled "RDEA119, a Potent,an...in Dextran Sulfate,Sodium (DSS) -- induced Chronic...ollege of Gastroenterology (ACG) 2008 Annual Meeti... data from a preclinical study of,RDEA119, the Com...
Breaking Medicine Technology:In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4The story of Max Perutz a pioneering biologist with a remarkable passion for life 2832 1Nominations for Outstanding Cancer Survivor Award Being Accepted by Karmanos Cancer Institute Through April 27 16388 1Nominations for Outstanding Cancer Survivor Award Being Accepted by Karmanos Cancer Institute Through April 27 16388 2Obesity Costs U S Companies as Much as 2445 Billion a Year The Conference Board Reports 16384 1Obesity Costs U S Companies as Much as 2445 Billion a Year The Conference Board Reports 16384 2Obesity Costs U S Companies as Much as 2445 Billion a Year The Conference Board Reports 16384 3ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 1ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 2ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 3ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 4ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 5ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 6ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 7
...ontinuous low-flow nebulizer performance. Patented...allows for optimal medication and Heliox delivery ...vere asthma, COPD and pneumonia in both routine an... mouth and T-piece to deliver high-output, low-flo...
... diverse medical products for more than 58 years. ...anding reputation for innovation, quality and cust...ecognized brands include the Labtron® line of ... products, Bristoline® microscopes, HealthTeam...
...contains everything the health care professional n...ickly and efficiently: 7 nebulizers, T-piece and m...yringe and needle., ,Shipped 5 kits per case., ,...ed Use: AsthmaKit is a procedural kit providing th...
Infant Nebulizer Kit W/Misty-Nebulizer 30/CS CE Mark Only
Medicine Products: